Table 1.
Technology | Type of labeling required | Ability to detect many post-translational modifications | Biomolecules that are optimally quantified | Approximate dynamic range (and reference) | Number of proteins/spots quantified (and reference) |
Two-dimensional gel electrophoresis | Silver staining | Yes | Naturally occurring forms of proteins larger than 10 kDa | 10 [9] | 1,500 [8] |
Differential two-dimensional fluorescence gel electrophoresis (DIGE) | In vitro with Cy2, Cy3 or CY5 fluorophores at primary amines | Yes | Naturally occurring forms of proteins larger than 10 kDa | 10,000 [9] | 1,100 [51] |
SELDI- or MALDI-MS disease biomarker discovery | None | Yes | Naturally occurring forms of proteins smaller than 10 kDa | 25 | Not applicable |
Isotope-coded affinity tag (ICAT) - LC/MS | In vitro with H1/D or C12/C13 ICAT reagent at cysteine | No | Cysteine-containing tryptic peptides from digests of protein extracts | 10,000* | 496 [18] |
N14/N15 - LC/MS | In vivo at nitrogens in amino acids | Yes | Tryptic peptides from digests of protein extracts | 10,000 [19] | 872 [20] |
*Assumed to be similar to that for multidimensional protein identification. Abbreviations: SELDI-MS, surface-enhanced laser desorption ionization mass spectrometry; MALDI-MS, matrix-assisted laser desorption ionization mass spectrometry; LC/MS, liquid chromatography and mass spectrometry.